NCT07234110
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Hematology Hospital of Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Clinical trial condition
Relapsed and Refractory CD5 Hematological Tumors
Explore clinical trials studying Relapsed and Refractory CD5 Hematological Tumors. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study